logo

For the Inventor, By the Inventor

London, United Kingdom

Pulmocide Limited


USPTO Granted Patents = 22


Trademarks = 2

Forward Citations = 78

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Kazuhiro Ito (21 out of 49 patents)

silverMedal Peter Strong (21 out of 38 patents)

bronzeMedal Stuart Thomas Onions (15 out of 65 patents)

4.  Peter John Murray (14 out of 38 patents)

5.  Thomas Christopher Colley (13 out of 14 patents)

6.  Mihiro Sunose (13 out of 16 patents)

7.  Garth Rapeport (10 out of 11 patents)

8.  Simon Fraser Hunt (8 out of 8 patents)

9.  Vladimir Sherbukhin (8 out of 8 patents)

10.  Daniel William Brookes (8 out of 8 patents)

11.  Euan Alexander Fraser Fordyce (7 out of 20 patents)

12.  Matthew Stephen Coates (5 out of 5 patents)

13.  Matthew McConville (3 out of 3 patents)

14.  Osama Suleiman (1 out of 11 patents)

15.  John King-Underwood (1 out of 39 patents)


22 patents:

1. 12491182 - Polymorphs of triazole antifungal compound PC945 (2025-12-09),
2. 12269814 - Process for preparing a compound useful to treat mycoses (2025-04-08),
3. 11661415 - Process for preparing a compound useful to treat mycoses (2023-05-30),
4. 11008307 - Compounds which are used in the preparation of the compound of formula (I) (2021-05-18),
5. 10858345 - Process for preparing a compound useful to treat mycoses (2020-12-08),
6. 10800762 - Compounds which are used in the preparation of the compound of formula (II) (2020-10-13),
7. 10662179 - Process for preparing a compound useful to treat mycoses (2020-05-26),
8. 10626126 - Compounds (2020-04-21),
9. 10513511 - Aqueous suspension formulation comprising 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl) or a pharmaceutically acceptable salt thereof (2019-12-24),
10. 10487073 - Compounds which are used in the preparation of the compound of formula (I) (2019-11-26),
11. 10472375 - 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative (2019-11-12),
12. 10450304 - Compound useful to treat mycoses (2019-10-22),
13. 10344022 - Compound useful to treat mycoses (2019-07-09),
14. 10280155 - Process for preparing 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-N-((1S,2S)-2-hydroxycyclohexyl) benzamide or a pharmaceutically acceptable salt thereof (2019-05-07),
15. 10273249 - 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative (2019-04-30),
PULMOCIDE LIMITED is a biopharmaceutical company dedicated to developing novel therapeutics for the treatment of respiratory diseases. With a focus on innovative drug discovery and development, PULMOCIDE aims to address unmet medical needs in the field of pulmonary medicine. Their extensive research efforts and commitment to improving patient outcomes position them as a leader in the respiratory pharmaceutical industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#147 in London

#804 in United Kingdom

#27,908 in the World

...
London, United Kingdom

Pulmocide Limited

Forward Citations = 78

23 inventors:

goldMedal Kazuhiro Ito (21 out of 49 patents)

silverMedal Peter Strong (21 out of 38 patents)

bronzeMedal Stuart Thomas Onions (15 out of 65 patents)

4.  Peter John Murray (14 out of 38 patents)

5.  Thomas Christopher Colley (13 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…